BIOCON

Abraxane-paclitax nab

ABRAXANE contains Drug / Molecule called “PACLITAXEL WITH HUMAN ALBUMIN” (Protein bound). It is biotechnologically derived product which combines paclitaxel with naturally occurring human protein (albumin) which could be used as injectable suspension.It uses nanotechnology (approx. 130 nm) with advantages of albumin that acts as the body's key transporter of nutrients and accumulates in tumor tissues.

ABRAXANE is an advanced taxane therapy for the treatment of breast cancer. This unique product eliminates the need for chemical solvents and allows for higher doses of paclitaxel without compromising safety and tolerability.

Details
Specification

Indication

Abraxane is mostly used to treat breast cancer after failure of combination chemotherapy for metastaticdisease or relapse within 6 months of adjuvant chemotherapy. It is also under various stages of investigation for the treatment of cancers in non-small cell lung, malignant melanoma, pancreatic and gastric.

Note

Precaution

Abraxane is a prescription drug and should be used under proper medical guidance and advice.
Myelosuppression and sensory neuropathy.
Drug in combination with gemcitabine may cause sepsis.
Severe hypersensitivity reactions may occur.

Updated On Oct 19, 2019 by Admin

Strength

100 mg

Packing

Vial (as a lyophilized powder, to be reconstituted for intravenous administration).

Storage

Store between 20°C to 25°C.

Was this page helpful?

☆ ☆ ☆ ☆ ☆

Not Upto Date Insufficient Helpful

Any suggestions or inputs for Shubhampharma.

Abraxane-paclitax nab also available as

CIPLA LTD.

Paclitax nab

Paclitax Nab contains Drug / Molecule called “Paclitaxel with Human Albumin” (Protein bound). Nanoparticle albumin-bound paclitaxel is novel formulation which contains human protein that carries nutrients throughout the body to deliver the paclitaxel.